Sulfadiazine has a broad spectrum and strong antibacterial activity against Gram-positive and negative bacteria, it can be used for meningococcus, pneumococcus, Neisseria gonorrhoeae, dissolved plus streptococcal infection treatment, through the blood-brain barrier into the cerebrospinal fluid, It has been used for the treatment of epidemic meningitis drug of choice. Antibacterial mechanism with para aminobenzoic acid (PABA) Competition bacterial dihydrofolate synthase, leading to bacterial folic acid synthesis blocked leaving the bacterial growth, reproduction frustrated. The product is in the sulfadoxine-pyrimethamine, Enterobacteriaceae non-producing Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae, Escherichia coli, Klebsiella, Salmonella, Shigella, etc., leaching , meningococcus, Haemophilus influenzae has an antibacterial effect, in addition to Chlamydia trachomatis in vitro, star slave card bacteria, Plasmodium and Toxoplasma gondii also have antimicrobial activity.
In the global pharmaceutical raw materials market, China, as a big country of producing raw materials satisfied buyers demands all over the world. Nevertheless, there are so may manufacturers and suppliers in this irregular market, which makes it difficult for buyers to choose an honest and a reliable supplier as a partner, especially for the buyers first time to purchase.
Hubei Ocean Biotech Co,. Ltd, China pharmaceutical raw material supplier, with credible service and the honest management, we have gained good reputation at domestic and abroad market. The main cause is not only for our honesty and service, but more importantly for our quality insurance about the products we offer. That's why customers choose us, our products are rest assured to buy, it is our honesty and service solved customers worries, so that we could be able to extend our market and serve more people. If you are looking for an honest and reliable Chinese supplier like us, Please feel free to contact us, we sincerely looking forward to your consult.
没有评论:
发表评论